<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E4757A6E-7326-472B-9979-B47D77A65446"><gtr:id>E4757A6E-7326-472B-9979-B47D77A65446</gtr:id><gtr:name>Aberystwyth University</gtr:name><gtr:department>IBERS</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>King Street</gtr:line2><gtr:line3>Ceredigion</gtr:line3><gtr:line4>Aberystwyth</gtr:line4><gtr:line5>Dyfed</gtr:line5><gtr:postCode>SY23 2AX</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E4757A6E-7326-472B-9979-B47D77A65446"><gtr:id>E4757A6E-7326-472B-9979-B47D77A65446</gtr:id><gtr:name>Aberystwyth University</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>King Street</gtr:line2><gtr:line3>Ceredigion</gtr:line3><gtr:line4>Aberystwyth</gtr:line4><gtr:line5>Dyfed</gtr:line5><gtr:postCode>SY23 2AX</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5EB9050A-44F7-441F-86BF-B8EA2831E009"><gtr:id>5EB9050A-44F7-441F-86BF-B8EA2831E009</gtr:id><gtr:firstName>Joseph</gtr:firstName><gtr:surname>Gallagher</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FI532953%2F1"><gtr:id>3350ED29-9F7E-42E3-9AC9-B691841E87A1</gtr:id><gtr:title>The commercial exploitation of novel prebiotics based on oligomeric fructans</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/I532953/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2011-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>109608</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Discussion with Institute of Food Research (ISPG)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EEFF525C-6C81-4BBF-A602-7A018FC9BB54</gtr:id><gtr:impact>Presentation and discussions with senior management on integration of Institute Strategic funding grants.</gtr:impact><gtr:outcomeId>58c9e7d0984497.83961232</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>109609</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The commercial exploitation of novel prebiotics based on oligomeric fructans</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/I532953/1</gtr:fundingRef><gtr:id>662C5C5D-C738-4362-9250-1A0725B91EDD</gtr:id><gtr:outcomeId>58beec62a17754.63716947</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>European Regional Development Fund (ERDF)</gtr:department><gtr:description>BEACON + Biorefining Center</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>99091393-6E47-4620-94F1-3D56B2967C60</gtr:id><gtr:outcomeId>58c58f69226cf9.90477859</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Identification and method for isolation of pre-biotics from grasses</gtr:description><gtr:grantRef>BB/I532953/1</gtr:grantRef><gtr:id>6A847CA2-7E9F-417F-AD31-B1496D97E664</gtr:id><gtr:impact>To early, in development</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56e04b02a75e19.07954360</gtr:outcomeId><gtr:patentId>PCT/ GB2014/ 053414</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Prebiotic composition</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>Short chain fructans make good pre-biotics enhancing the growth of 'good bacteria' and having a pre-biotic index better than commercially available fructose based pre-biotics. A number of methods were tested to increase the percentage of short chain fructans compared to the larger molecules along with methods of isolation to reduce potential processing costs. Together with work from other projects, the longer chains could be hydrolysied to shorter chain molecules using endo-cutting enzymes, while membrane systems could be used for purification rather than ethanol precipitation. Data showed that a reproducible product could be obtained and that it had the same pre-biotic index as the original material.</gtr:description><gtr:exploitationPathways>We will now start to carry out animal trails to prove to industry the potential of these novel pre-biotics</gtr:exploitationPathways><gtr:id>1FD3F55D-FAB8-41F2-A55C-728CA4F4C41F</gtr:id><gtr:outcomeId>56e04f6ebdfe69.02895819</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Chemicals</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1C254720-B7E6-4B1B-AED3-5336802604FE</gtr:id><gtr:title>Determination of the degree of polymerisation of fructans from ryegrass and chicory using MALDI-TOF Mass Spectrometry and Gel Permeation Chromatography coupled to multiangle laser light scattering</gtr:title><gtr:parentPublicationTitle>Food Hydrocolloids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe908793bffc58c38e75ab288435aea4"><gtr:id>fe908793bffc58c38e75ab288435aea4</gtr:id><gtr:otherNames>Evans M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56df03f43ff050.76508480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD6FB899-90C3-4819-A888-E649386E0C4E</gtr:id><gtr:title>Novel rapid method for the characterisation of polymeric sugars from macroalgae.</gtr:title><gtr:parentPublicationTitle>Journal of applied phycology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6eedb1c7aa2789d53854a78be31ec994"><gtr:id>6eedb1c7aa2789d53854a78be31ec994</gtr:id><gtr:otherNames>Spicer SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0921-8971</gtr:issn><gtr:outcomeId>58bd995fe08d96.17688068</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/I532953/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>